| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |